Get the Stockscreener App
12.99
4.42%
0.55
Coeptis Therapeutics Holdings Inc stock is traded at $12.99, with a volume of 19,078.
It is up +4.42% in the last 24 hours and up +7.89% over the past month.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
See More
Previous Close:
$12.44
Open:
$12.225
24h Volume:
19,078
Relative Volume:
0.39
Market Cap:
$80.84M
Revenue:
$1.36M
Net Income/Loss:
$-12.28M
P/E Ratio:
-4.6386
EPS:
-2.8004
Net Cash Flow:
$-8.60M
1W Performance:
+19.72%
1M Performance:
+7.89%
6M Performance:
-15.04%
1Y Performance:
+39.38%
1-Day Range:
$12.22
$12.99
1-Week Range:
$10.94
$12.99
52-Week Range:
$6.26
$21.41
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
Name
Coeptis Therapeutics Holdings Inc
Sector
Industry
Phone
724-934-6467
Address
105 BRADFORD ROAD, SUITE 420, WEXFORD
Compare COEP vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
6.99 | 2.70M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.82 | 2.55B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
19.85 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
3.70 | 356.14M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
5.81 | 315.27M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
46.21 | 0 | 0 | 0 | 0 | 0.00 |
Coeptis Therapeutics Holdings Inc Stock (COEP) Latest News
What is Coeptis Therapeutics Holdings Incs revenue forecast2026 Fed Impact & High Return Trade Guides - baoquankhu1.vn
Coeptis Therapeutics, Z Squared announce merger agreement - MSN
Breakouts Watch: Can Coeptis Therapeutics Holdings Inc Equity Warrant expand into new marketsAnalyst Downgrade & Weekly Momentum Picks - baoquankhu1.vn
Aug Rallies: Can Coeptis Therapeutics Holdings Inc Equity Warrant expand into new marketsDay Trade & Scalable Portfolio Growth Methods - baoquankhu1.vn
Market Trends: What is the long term forecast for Coeptis Therapeutics Holdings Inc Equity Warrant stockWeekly Market Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
History Review: What is the Moat Score of Coeptis Therapeutics Holdings IncWeekly Loss Report & Daily Profit Focused Screening - baoquankhu1.vn
COEP Stock Price, Quote & Chart | COEPTIS THERAPEUTICS HOLDING (NASDAQ:COEP) - ChartMill
Aug Update: Can AvidXchange Holdings Inc disrupt its industryChart Signals & Weekly Momentum Picks - baoquankhu1.vn
Market Rankings: Is ATLC a top pick in the sectorMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Insider Sell: Is Treasure Global Inc stock showing strong momentum2026 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Value Recap: Can Okeanis Eco Tankers Corp ride the EV waveTrade Exit Summary & Fast Gain Stock Tips - baoquankhu1.vn
Coeptis Therapeutics Announces Nasdaq Approval and Merger with Z Squared to Become Leading Public Dogecoin Miner - Minichart
Coeptis Wins Nasdaq Nod for Z Squared Merger Listing - TipRanks
Nasdaq clears Coeptis (COEP) post-merger Z Squared stock to trade as ZSQR - Stock Titan
Coeptis to List Post-Merger Common Stock as ZSQR on Nasdaq Global Market - TradingView — Track All Markets
Weekly Recap: What is the implied volatility of Processa Pharmaceuticals Inc2026 Chart Watch & High Conviction Buy Zone Picks - baoquankhu1.vn
Nasdaq Approves Listing for Coeptis Therapeutics Holdings, Inc. Post-Merger with Z Squared Inc. - Quiver Quantitative
Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing Application - Benzinga
Nasdaq approves ZSQR listing, putting Coeptis merger on track for Q2 - Stock Titan
(COEP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
COEP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
COEP PE Ratio & Valuation, Is COEP Overvalued - Intellectia AI
Analyst Upgrade: Can Coeptis Therapeutics Holdings Inc grow without external funding2026 Price Swings & Consistent Income Trade Recommendations - baoquankhu1.vn
Patterns Watch: What is the Moat Score of Coeptis Therapeutics Holdings Inc2026 Reactions & Smart Allocation Stock Tips - baoquankhu1.vn
Vanguard amendment lists 0 shares in Coeptis Therapeutics (COEP) - Stock Titan
Portfolio Shifts: Will Coeptis Therapeutics Holdings Inc Equity Warrant benefit from rate cuts2026 Performance Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
How (COEP) Movements Inform Risk Allocation Models - Stock Traders Daily
Aug Sectors: Whats the beta of Coeptis Therapeutics Holdings Inc stock2026 Price Swings & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Coeptis Therapeutics (NASDAQ:COEP) Trading Down 2.1%Here's What Happened - MarketBeat
[424B3] Coeptis Therapeutics Holdings, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
3.92M‑share resale filing; Yorkville tied to 3.74M shares (COEP) - Stock Titan
COEP SEC FilingsCoeptis Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Pullback Watch: Is Coeptis Therapeutics Holdings Inc stock showing strong momentum2026 Setups & Reliable Breakout Forecasts - baoquankhu1.vn
Coeptis Therapeutics Holdings, Inc. 2025 Annual Report Highlights: Biotechnology Innovations, AI Technology Expansion, and Strategic Growth Risks - Minichart
Coeptis Therapeutics Holdings 2025 10-K: $1.36M Revenue, Operating Loss $14.23M - TradingView
Coeptis Therapeutics (NASDAQ: COEP) posts 2025 loss and plans Z Squared merger, biotech spin-out - Stock Titan
Coeptis Therapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Coeptis Therapeutics Holdings, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Market Catalysts: Will Coeptis Therapeutics Holdings Inc. Equity Warrant benefit from rate cuts2026 Technical Overview & Verified Short-Term Plans - baoquankhu1.vn
Trading Recap: Will Coeptis Therapeutics Holdings Inc Equity Warrant benefit from rate cuts2026 Technical Overview & Accurate Intraday Trading Signals - baoquankhu1.vn
Trading Systems Reacting to (COEP) Volatility - Stock Traders Daily
Vanderbilt Report: Coeptis / Z Squared Merger Enters Final StretchClosing Imminent as Institutional Tailwinds Build - 富途牛牛
Aug Movers: Can Coeptis Therapeutics Holdings Inc Equity Warrant stock double in the next year2026 Sector Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
How Coeptis Therapeutics Holdings Inc. stock performs during Fed tightening cycles2026 Levels & Fast Moving Market Watchlists - Naître et grandir
What momentum indicators show for Coeptis Therapeutics Holdings Inc. stock - Naître et grandir
Investment Report: Should value investors consider Coeptis Therapeutics Holdings Inc Equity Warrant2025 Major Catalysts & Weekly Top Gainers Trade List - baoquankhu1.vn
Sell Signal: Should I hold or sell Coeptis Therapeutics Holdings Inc Equity Warrant nowPortfolio Return Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Forecast Cut: Is Coeptis Therapeutics Holdings Inc a speculative investmentJuly 2025 Weekly Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
How Coeptis Therapeutics Holdings Inc. (COEP) Affects Rotational Strategy Timing - Stock Traders Daily
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 2.4% – Should You Sell? - Defense World
Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 2.4%Should You Sell? - MarketBeat
Coeptis Therapeutics Holdings Inc Stock (COEP) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):